{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:54:35Z","timestamp":1774292075907,"version":"3.50.1"},"reference-count":31,"publisher":"Becaris Publishing Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>\n            <jats:bold>Aim:<\/jats:bold>\n            To evaluate the effectiveness and safety of anti-TNF drugs for ankylosing spondylitis.\n            <jats:bold>Materials &amp; methods:<\/jats:bold>\n            A prospective cohort study was performed at a pharmacy in the Brazilian Public Health System. Effectiveness by Bath Ankylosing Spondylitis Disease Activity Index, functionality by Health Assessment Questionnaire Disability Index, quality of life by European Quality of Life Five-Dimensions and safety was assessed at 6 and 12\u00a0months of follow-up.\n            <jats:bold>Results:<\/jats:bold>\n            \u00a0About\u00a0160 patients started the treatment with adalimumab, etanercept or infliximab. There was a statistically significant improvement in disease activity, functionality and quality of life at 6 and 12\u00a0months (p\u00a0&lt;\u00a00.05).\n            <jats:bold>Conclusion:<\/jats:bold>\n            This real-world study has shown that anti-TNF drugs are effective and well tolerated for ankylosing spondylitis patients.\n          <\/jats:p>","DOI":"10.2217\/cer-2020-0275","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T14:08:30Z","timestamp":1615990110000},"page":"509-517","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study"],"prefix":"10.57264","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4024-0108","authenticated-orcid":false,"given":"Pedro Ricardo","family":"K\u00f6mel Pimenta","sequence":"first","affiliation":[{"name":"Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, President Ant\u00f4nio Carlos Avenue, Campus Pampulha, Belo Horizonte, Minas Gerais\u00a06627, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-7249","authenticated-orcid":false,"given":"Michael Ruberson","family":"Ribeiro da Silva","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, President Ant\u00f4nio Carlos Avenue, Campus Pampulha, Belo Horizonte, Minas Gerais\u00a06627, Brazil"},{"name":"Health Assessment, Technology\u00a0&amp; Economy Group, Center for Exact, Natural &amp; Health Sciences, Federal University of Esp\u00edrito Santo, Alto Universit\u00e1rio S\/N, Guararema, Alegre, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-0658","authenticated-orcid":false,"given":"J\u00e9ssica Barreto","family":"Ribeiro dos Santos","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, President Ant\u00f4nio Carlos Avenue, Campus Pampulha, Belo Horizonte, Minas Gerais\u00a06627, Brazil"},{"name":"Health Assessment, Technology\u00a0&amp; Economy Group, Center for Exact, Natural &amp; Health Sciences, Federal University of Esp\u00edrito Santo, Alto Universit\u00e1rio S\/N, Guararema, Alegre, Esp\u00edrito Santo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-7493","authenticated-orcid":false,"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[{"name":"Medicine School, Federal University of Minas Gerais, Av\u00a0Prof Alfredo Balena, Belo Horizonte, Minas Gerais\u00a0190, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5880-5261","authenticated-orcid":false,"given":"Francisco de","family":"Assis Acurcio","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, President Ant\u00f4nio Carlos Avenue, Campus Pampulha, Belo Horizonte, Minas Gerais\u00a06627, Brazil"},{"name":"Medicine School, Federal University of Minas Gerais, Av\u00a0Prof Alfredo Balena, Belo Horizonte, Minas Gerais\u00a0190, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0210-0721","authenticated-orcid":false,"given":"Juliana","family":"Alvares-Teodoro","sequence":"additional","affiliation":[{"name":"Department of Social Pharmacy, College of Pharmacy, Federal University of Minas Gerais, President Ant\u00f4nio Carlos Avenue, Campus Pampulha, Belo Horizonte, Minas Gerais\u00a06627, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"36897","reference":[{"issue":"9570","key":"e_1_3_5_3_2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun J","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet 369(9570), 1379\u20131390 (2007).","journal-title":"Lancet"},{"issue":"2","key":"e_1_3_5_4_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pop.2018.02.005","article-title":"The seronegative spondyloarthropathies","volume":"45","author":"Duba AS","year":"2018","unstructured":"Duba AS, Mathew SD. The seronegative spondyloarthropathies. Prim. Care 45(2), 271\u2013287 (2018).","journal-title":"Prim. Care"},{"issue":"2","key":"e_1_3_5_5_2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward MM","year":"2016","unstructured":"Ward MM, Deodhar A, Akl EA American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 68(2), 282\u2013298 (2016).","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"e_1_3_5_6_2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/1756-185X.13560","article-title":"Hearing loss in ankylosing spondylitis","volume":"22","author":"Ajmani S","year":"2019","unstructured":"Ajmani S, Keshri A, Srivastava R, Aggarwal A, Lawrence A. Hearing loss in ankylosing spondylitis. Int. J. Rheum. Dis. 22(7), 1202\u20131208 (2019).","journal-title":"Int. J. Rheum. Dis."},{"issue":"5","key":"e_1_3_5_7_2","first-page":"432","article-title":"Clinical characteristics and frequency of TLR4 polymorphisms in Brazilian patients with ankylosing spondylitis","volume":"56","author":"Machado NP","year":"2016","unstructured":"Machado NP, Nogueira E, Oseki K Clinical characteristics and frequency of TLR4 polymorphisms in Brazilian patients with ankylosing spondylitis. Rev. Bras. Reumatol. Engl. Ed. 56(5), 432\u2013440 (2016).","journal-title":"Rev. Bras. Reumatol. Engl. Ed."},{"issue":"4","key":"e_1_3_5_8_2","first-page":"233","article-title":"First update on the Brazilian consensus for the diagnosis and treatment of spondyloarthropathies: ankylosing spondylitis and psoriatic arthritis","volume":"47","author":"Sampaio-Barros PD","year":"2007","unstructured":"Sampaio-Barros PD, Valder\u00edlio FA, Bonfiglioli R First update on the Brazilian consensus for the diagnosis and treatment of spondyloarthropathies: ankylosing spondylitis and psoriatic arthritis. Rev. Bras. Reumatol. 47(4), 233\u2013242 (2007).","journal-title":"Rev. Bras. Reumatol."},{"key":"e_1_3_5_9_2","volume-title":"Pharmaceutical Assistance","author":"BRAZIL","year":"2019","unstructured":"BRAZIL. Specialized component of pharmaceutical assistance (CEAF). Pharmaceutical Assistance Ministry of Health, Bras\u00edlia, Brazil (2019). www.saude.gov.br\/assistencia-farmaceutica\/medicamentos-rename\/componente-especializado-da-assistencia-farmaceutica-ceaf"},{"issue":"4","key":"e_1_3_5_10_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s11096-019-00859-7","article-title":"Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study","volume":"41","author":"Wro\u0144ski J","year":"2019","unstructured":"Wro\u0144ski J, Fiedor P, G\u0142uszko P. Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study. Int. J. Clin. Pharm. 41(4), 864\u2013871 (2019).","journal-title":"Int. J. Clin. Pharm."},{"issue":"25","key":"e_1_3_5_11_2","doi-asserted-by":"crossref","first-page":"e7145","DOI":"10.1097\/MD.0000000000007145","article-title":"Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: ameta-analysis","volume":"96","author":"Ma Z","year":"2017","unstructured":"Ma Z, Liu X, Xu Xe Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: ameta-analysis. Medicine (Baltimore) 96(25), e7145 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_5_12_2","volume-title":"Secretariat of Science, Technology and Strategic Inputs and Secretariat of Health Care, [2018].","author":"BRAZIL","year":"2018","unstructured":"BRAZIL. Joint ordinance n\u00b025 \/ 2018. Approves the clinical protocol and therapeutic guidelines for ankylosing spondylitis. In: Secretariat of Science, Technology and Strategic Inputs and Secretariat of Health Care, [2018]. DF: Ministry of Health, Bras\u00edlia, Brazik (2018). http:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2019\/abril\/29\/Portaria-Conjunta-n--25---PCDT-espondilite-ancilosante.29.04.2019.pdf"},{"issue":"2","key":"e_1_3_5_13_2","first-page":"143","article-title":"A Import\u00e2ncia da Avalia\u00e7\u00e3o de Tecnologias para o Sistema \u00danico de Sa\u00fade","volume":"14","author":"Elias FTS","year":"2013","unstructured":"Elias FTS. A Import\u00e2ncia da Avalia\u00e7\u00e3o de Tecnologias para o Sistema \u00danico de Sa\u00fade. BIS 14(2), 143\u2013150 (2013).","journal-title":"BIS"},{"issue":"2","key":"e_1_3_5_14_2","first-page":"143","article-title":"A import\u00e2ncia da avalia\u00e7\u00e3o de tecnologias para o sistema \u00fanico de sa\u00fade","volume":"14","author":"Elias FTS","year":"2013","unstructured":"Elias FTS. A import\u00e2ncia da avalia\u00e7\u00e3o de tecnologias para o sistema \u00fanico de sa\u00fade. BIS 14(2), 143\u2013150 (2013).","journal-title":"BIS"},{"issue":"6","key":"e_1_3_5_15_2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit M","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann. Rheum. Dis. 68(6), 777\u2013783 (2009).","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"e_1_3_5_16_2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s10067-006-0479-8","article-title":"Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation","volume":"26","author":"Shinjo SK","year":"2007","unstructured":"Shinjo SK, Gon\u00e7alves R, Kowalski S, Gon\u00e7alves CR. Brazilian-Portuguese version of the Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) in patients with ankylosing spondylitis: a translation, cross-cultural adaptation, and validation. Clin. Rheumatol. 26(8), 1254\u20131258 (2007).","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"e_1_3_5_17_2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3899\/jrheum.181415","article-title":"Multimorbidity is common in axial spondyloarthropathy and is associated with worse disease outcomes: results from the ASRI cohort","volume":"47","author":"Fitzgerald G","year":"2019","unstructured":"Fitzgerald G, Gallagher P, O'SHEA F. Multimorbidity is common in axial spondyloarthropathy and is associated with worse disease outcomes: results from the ASRI cohort. J. Rheum. 47(2), 218\u2013226 (2019).","journal-title":"J. Rheum."},{"key":"e_1_3_5_18_2","unstructured":"Nucleus of evaluation and technology in health-nats inc. Qaly Brazil. National Institute of Cardiology (2019). http:\/\/natsinc.org\/wpress\/euroqol\/?page_id=767"},{"issue":"3","key":"e_1_3_5_19_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/rheumatology\/kep422","article-title":"BSR Biologics register. Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register","volume":"49","author":"Lord PA","year":"2010","unstructured":"Lord PA, Farragher TM, Lunt M BSR Biologics register. Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 49(3), 563\u2013570 (2010).","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_3_5_20_2","first-page":"50","article-title":"Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"22","author":"Machado MA","year":"2016","unstructured":"Machado MA, Moura CS, Ferr\u00e9 F, Bernatsky S, Rahme E, Acurcio Fde A. Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis. Rev. Saude Publica 22, 50 (2016).","journal-title":"Rev. Saude Publica"},{"issue":"5","key":"e_1_3_5_21_2","first-page":"432","article-title":"Clinical characteristics and frequency of TLR4 polymorphisms in Brazilian patients with ankylosing spondylitis","volume":"56","author":"Machado NP","year":"2016","unstructured":"Machado NP, Nogueira E, Oseki K Clinical characteristics and frequency of TLR4 polymorphisms in Brazilian patients with ankylosing spondylitis. Rev. Bras. Reumatol. Engl. Ed. 56(5), 432\u2013440 (2016).","journal-title":"Rev. Bras. Reumatol. Engl. Ed."},{"issue":"4","key":"e_1_3_5_22_2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/03007995.2020.1722945","article-title":"Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study","volume":"36","author":"Acurcio FA","year":"2020","unstructured":"Acurcio FA, Guerra Junior AA, da Silva MRR Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study. Curr. Med. Res. Opin. 36(4), 677\u2013686 (2020).","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"e_1_3_5_23_2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/annrheumdis-2014-205322","article-title":"Efficacy of TNF\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis","volume":"74","author":"Callhoff J","year":"2015","unstructured":"Callhoff J, Sieper J, Wei\u00df A, Zink A, Listing J. Efficacy of TNF\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann. Rheum. Dis. 74(6), 1241\u20131248 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"e_1_3_5_24_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3899\/jrheum.151404","article-title":"Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors","volume":"43","author":"Lubrano E","year":"2016","unstructured":"Lubrano E, Parsons WJ, Perrotta FM. Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors. J. Rheumatol. 43(5), 918\u2013923 (2016).","journal-title":"J. Rheumatol."},{"key":"e_1_3_5_25_2","volume-title":"IBGE","author":"BRAZIL","year":"2020","unstructured":"BRAZIL. National Household Sample Survey-PNAD. IBGE Brazilian Institute of Geography and Statistics, Bras\u00edlia, Brazil (2020). www.ibge.gov.br\/estatisticas\/sociais\/educacao\/9127-pesquisa-nacional-por-amostra-de-domicilios.html?=&t=o-que-e"},{"key":"e_1_3_5_26_2","volume-title":"IBGE","author":"BRAZIL","year":"2020","unstructured":"BRAZIL. National Household Sample Survey-PNAD. IBGE Brazilian Institute of Geography and Statistics, Bras\u00edlia, Brazil (2020). https:\/\/agenciadenoticias.ibge.gov.br\/agencia-sala-de-imprensa\/2013-agencia-de-noticias\/releases\/18992-pnad-continua-2016-51-da-populacao-com-25-anos-ou-mais-do-brasil-possessed-at-maximum-the-complete-elementary-education-access"},{"issue":"6","key":"e_1_3_5_27_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","article-title":"Gender differences in axial spondyloarthritis: women are not so lucky","volume":"20","author":"Rusman T","year":"2018","unstructured":"Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE. Gender differences in axial spondyloarthritis: women are not so lucky. Curr. Rheumatol. Rep. 20(6), 35 (2018).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"e_1_3_5_28_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk C","year":"2012","unstructured":"Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum. Dis. Clin. North Am. 38(3), 441\u2013476 (2012).","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"5","key":"e_1_3_5_29_2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s11096-015-0124-1","article-title":"Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice","volume":"37","author":"Escudero-Vilaplana V","year":"2015","unstructured":"Escudero-Vilaplana V, Ram\u00edrez-Herr\u00e1iz E, Ala\u00f1\u00f3n-Plaza E Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice. Int. J. Clin. Pharm. 37(5), 808\u2013814 (2015).","journal-title":"Int. J. Clin. Pharm."},{"issue":"2","key":"e_1_3_5_30_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.anr.2019.02.004","article-title":"Effects of multidisciplinary team-based nurse-led transitional care on clinical outcomes and quality of life in patients with ankylosing spondylitis","volume":"13","author":"Liang L","year":"2019","unstructured":"Liang L, Pan Y, Wu D, Pang Y, Xie Y, Fang H. Effects of multidisciplinary team-based nurse-led transitional care on clinical outcomes and quality of life in patients with ankylosing spondylitis. Asian Nursing Research 13(2), 107\u2013114 (2019).","journal-title":"Asian Nursing Research"},{"issue":"4","key":"e_1_3_5_31_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jval.2015.02.016","article-title":"Modeling health state utility values in ankylosing spondylitis: comparisons of direct and indirect methods","volume":"18","author":"Wailoo A","year":"2015","unstructured":"Wailoo A, Hern\u00e1ndez M, Philips C, Brophy S, Siebert S. Modeling health state utility values in ankylosing spondylitis: comparisons of direct and indirect methods. Value Health 18(4), 425\u2013431 (2015).","journal-title":"Value Health"},{"key":"e_1_3_5_32_2","first-page":"25","article-title":"Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: a meta-analysis","volume":"96","author":"Zeren M","year":"2017","unstructured":"Zeren M, Xiaoping L, Xiaosheng X Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: a meta-analysis. Medicine (Baltimore) 96, 25 (2017).","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"e_1_3_5_33_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi S","year":"2016","unstructured":"Minozzi S, Bonovas S, Lytras T Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin. Drug Saf. 15(Suppl. 1), 11\u201334 (2016).","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.2217\/cer-2020-0275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T12:30:06Z","timestamp":1679229006000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.2217\/cer-2020-0275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.2217\/cer-2020-0275"],"URL":"https:\/\/doi.org\/10.2217\/cer-2020-0275","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}